Range
- - -
Vol / Avg.
-/1.4M
Div / Yield
-
52 Wk
3.07 - 11.74
Mkt Cap
812.4M
Payout Ratio
-
Open
-
P/E
-
EPS
0.01
Shares
119M
Outstanding
119M
Total Float
115.6M
Benzinga - Apr 15, 2021, 6:40AM
load more
Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. The company is also developing single and combination therapies to treat cancers and other life-threatening diseases. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe and Germany.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-10
REV
Q1 2021Est.ActualSurprise
EPS-0.1200.012 0.1320
REV9.570M14.060M4.490M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
AFMDAffimed0%812.4M

Affimed Frequently Asked Questions

Q

How do I buy Affimed (AFMD) stock?

A

You can purchase shares of Affimed (NASDAQ: AFMD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Affimed's (AFMD) competitors?

A

There are no as such competitors for Affimed.

Q

What is the target price for Affimed (AFMD) stock?

A

The latest price target for Affimed (NASDAQ: AFMD) was reported by Credit Suisse on March 31, 2021. The analyst firm set a price target for 15.00 expecting AFMD to rise to within 12 months (a possible 119.62% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Affimed (AFMD)?

A

The stock price for Affimed (NASDAQ: AFMD) is $6.83 last updated Thu Jul 29 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Affimed (AFMD) pay a dividend?

A

There are no upcoming dividends for Affimed.

Q

When is Affimed (NASDAQ:AFMD) reporting earnings?

A
Affimed’s Q2 earnings are confirmed for after-market on August 10, 2021.
Q

Is Affimed (AFMD) going to split?

A

There is no upcoming split for Affimed.

Q

What sector and industry does Affimed (AFMD) operate in?

A

Affimed is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.